Immediate Impact
3 from Science/Nature 63 standout
Citing Papers
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
2023 Standout
Works of Giovanni Pappagallo being referenced
Impact of Third-Generation Drugs on the Activity of First-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Meta-Analytical Approach
2009
Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm
1990
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Giovanni Pappagallo | 564 | 517 | 603 | 106 | 1.7k | |
| Satoshi Kitahara | 559 | 192 | 394 | 159 | 1.5k | |
| Dickon Hayne | 400 | 452 | 932 | 116 | 1.7k | |
| Massimo Maffezzini | 422 | 364 | 1124 | 106 | 1.9k | |
| Jian Huang | 648 | 536 | 1073 | 111 | 2.2k | |
| Sabine Bieri | 564 | 501 | 568 | 52 | 1.6k | |
| Qin Wang | 598 | 243 | 461 | 78 | 1.7k | |
| David D. Thiel | 963 | 236 | 805 | 136 | 1.8k | |
| Jun‐Eul Hwang | 464 | 638 | 560 | 104 | 1.7k | |
| R. C. Bennett | 247 | 579 | 960 | 89 | 2.1k | |
| Birgitte Grønkær Toft | 364 | 160 | 506 | 70 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...